Matt leads the business development and marketing efforts for Gilmartin Group. He brings over ten years of Wall Street experience with specific expertise in the healthcare sector. Prior to joining Gilmartin, Matt was a Managing Director at LifeSci Advisors focusing on business development as well as building and executing investor relations programs and financing strategies for client companies in healthcare. Previously, Matt spent several years at The Ruth Group. In addition to building and managing investor relations programs broadly there, he specialized in connecting emerging healthcare companies with institutional investors, venture capitalists, sell-side analysts, and the investment banking communities. Prior to The Ruth Group, Matt worked at Brean Capital in various roles including institutional sales, syndicate and corporate access, where he was Head of the Corporate Access desk and participated in several successful healthcare company financings over the course of his tenure.
Gilmartin Group is a strategic advisory firm that provides comprehensive service offerings throughout the lifespan of their client companies. At Gilmartin, the company leverages cross-discipline experience and a team approach to deliver results. Gilmartin recognizes that no two companies are alike, and the company tailors its work-scope for the unique needs and objectives of its clients. The ways in which Gilmartin partners with its clients can vary – building customized investor relations programs for emerging growth companies, large caps or micro-caps; acting as an outside strategic consultant; and helping private companies navigate Wall Street and create communications strategies. Gilmartin’s track record of success is fueled by their unparalleled experience and the strength of their relationships among actionable investors and industry veterans.